Campath 1H (Alemtuzumab) Combined With High-Dose Therapy and Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia.
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2016
At a glance
- Drugs Alemtuzumab (Primary) ; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Fludarabine; Melphalan
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 10 Aug 2016 Status changed from active, no longer recruiting to completed.
- 21 Aug 2007 Status change from recruiting to in progress.
- 11 Nov 2006 New trial record.